Literature DB >> 15866331

Review of novel particulate antigen delivery systems with special focus on treatment of type I allergy.

Isabella Schöll1, George Boltz-Nitulescu, Erika Jensen-Jarolim.   

Abstract

For the treatment of infectious diseases, cancer and allergy, the directed induction of an appropriate immune response is the ultimate goal. Therefore, with the development of pure, often very small proteins, peptides or DNA by molecular biology techniques, the research for suitable adjuvants or delivery systems became increasingly important. Particle formulations are made of a variety of materials, including lipids, proteins or amino acids, polysaccharides, polyacrylic substances or organic acids. Microparticles serve as vehicles and provide a depot for the entrapped or coupled antigen. The release occurs in a pulsatile or continuous manner, a feature, which is well controllable for many particulate systems. Particles attract antigen presenting cells to the administration site, thereby guaranteeing the efficient presentation of the antigen to the immune system. Importantly, particles also protect the entrapped substance. This is especially necessary after oral application to avoid gastric or tryptic breakdown. In this article, the design and construction of different antigen delivery systems and their immune effects, with special focus on the suitability for allergy treatment, are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15866331     DOI: 10.1016/j.jconrel.2004.12.020

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  14 in total

1.  Enhanced stimulation of anti-ovarian cancer CD8(+) T cells by dendritic cells loaded with nanoparticle encapsulated tumor antigen.

Authors:  Douglas J Hanlon; Paulomi B Aldo; Lesley Devine; Ayesha B Alvero; Anna K Engberg; Richard Edelson; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2011-01-18       Impact factor: 3.886

Review 2.  The ABC of clinical and experimental adjuvants--a brief overview.

Authors:  Richard Brunner; Erika Jensen-Jarolim; Isabella Pali-Schöll
Journal:  Immunol Lett       Date:  2009-11-04       Impact factor: 3.685

3.  Effector activity of peanut allergens: a critical role for Ara h 2, Ara h 6, and their variants.

Authors:  H S Porterfield; K S Murray; D G Schlichting; X Chen; K C Hansen; M W Duncan; S C Dreskin
Journal:  Clin Exp Allergy       Date:  2009-05-11       Impact factor: 5.018

4.  Immunogenicity of peanut proteins containing poly(anhydride) nanoparticles.

Authors:  Juliana De S Rebouças; Juan M Irache; Ana I Camacho; Gabriel Gastaminza; María L Sanz; Marta Ferrer; Carlos Gamazo
Journal:  Clin Vaccine Immunol       Date:  2014-06-04

Review 5.  Redefining the major peanut allergens.

Authors:  Yonghua Zhuang; Stephen C Dreskin
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

6.  Polymer nanoparticles containing tumor lysates as antigen delivery vehicles for dendritic cell-based antitumor immunotherapy.

Authors:  Shashi Prasad; Virginia Cody; Jennifer K Saucier-Sawyer; W Mark Saltzman; Clarence T Sasaki; Richard L Edelson; Martin A Birchall; Douglas J Hanlon
Journal:  Nanomedicine       Date:  2010-08-06       Impact factor: 5.307

Review 7.  Nanoparticulate adjuvants and delivery systems for allergen immunotherapy.

Authors:  Juliana De Souza Rebouças; Irene Esparza; Marta Ferrer; María Luisa Sanz; Juan Manuel Irache; Carlos Gamazo
Journal:  J Biomed Biotechnol       Date:  2012-02-26

Review 8.  Use of lectin-functionalized particles for oral immunotherapy.

Authors:  Susanne C Diesner; Xue-Yan Wang; Erika Jensen-Jarolim; Eva Untersmayr; Franz Gabor
Journal:  Ther Deliv       Date:  2012-02

9.  Characterization of Vibrio cholerae neuraminidase as an immunomodulator for novel formulation of oral allergy immunotherapy.

Authors:  Susanne C Diesner; Cornelia Bergmayr; Xue-Yan Wang; Denise Heiden; Sarah Exenberger; Franziska Roth-Walter; Philipp Starkl; Davide Ret; Isabella Pali-Schöll; Franz Gabor; Eva Untersmayr
Journal:  Clin Immunol       Date:  2018-03-30       Impact factor: 3.969

10.  Ontology representation and analysis of vaccine formulation and administration and their effects on vaccine immune responses.

Authors:  Yu Lin; Yongqun He
Journal:  J Biomed Semantics       Date:  2012-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.